|
Jan 11
|
Ascentage Pharma Presented at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Jan 2
|
Ascentage Pharma to Present at 42nd J.P. Morgan Healthcare Conference
|
|
Aug 7
|
Ascentage Pharma Received Clearance from U.S. FDA to Proceed with Global Registrational Phase III Clinical Trial for Lisaftoclax (APG-2575) in Previously Treated Patients with CLL/SLL
|